US Stock Market Closed

Dashboard

Rating & Fair Value

Fair Value Premium lock
Institutional Holdings

H

Financial Strength

H

Sustainable Growth

S

Industry Comparison

H

Management & Equity

B

Analyst Opinion

B

Leverage & Liquidity

S

Fundamental Variables

H

Rating Performance

FV Performance

*There is a current rating on the stock that is included in these numbers based on its performance so far

About

AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

CEO

Pascal Soriot

Employees

70,600

Industry

-

Sector

-

Headquarters

Cambridge

Exchange

New York Stock Exchange

Summary Stats

Market Cap

206B

Revenue

41.5B

Net Income

-1.06B

EPS

-$0.36

Price-to-Earnings

-186.3

Price-to-Book

5.67

Debt-to-Equity

1.76

News

Analyst Ratings

Price targets projected by 22 analysts

High

$77.00

Average

$62.02

Low

$42.00

Ratings calculated by 26 analysts

Buy

18

Hold

5

Sell

3

Last Dividend

Amount

$0.99

Dividend Date

Frequency

semi_annual

Dividend Yield

Earnings

Most Recent Earnings

Last Earnings for Q1 2022

Last Earnings

Above by $0.12

Actual

$0.95 +14.5%

Consensus

0.83

Report Date

Year Ago

0.82

Year Ago Change %

Up 15%

Actual vs Estimates

XX

xxx

Upcoming Estimates Unavailable

Expected EPS
-

-

Actual EPS
-

--

Competitors

star Favorites